Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) just unveiled an announcement.
MedPlus Health Services Ltd. has disclosed that its subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension of the drug license for one of its retail pharmacy stores located on S Rammurthy Road in Virajpet, Karnataka, following an order from the Assistant Director, Drugs Control Administration, Madikeri Circle, under Rule 65 of the Drugs and Cosmetics Act, 1940 and associated Rules. The company estimates a potential revenue loss of approximately Rs 0.74 lakh from this temporary suspension, indicating that the operational and financial impact is limited and localized to a single outlet, with no broader disruption to MedPlus’s overall retail network or core business activities communicated at this time.
More about MedPlus Health Services Ltd.
MedPlus Health Services Limited operates in the Indian healthcare and pharmaceutical retail sector, running a chain of pharmacies through subsidiaries such as Optival Health Solutions Private Limited. The company focuses on retail distribution of drugs and health products across multiple states, including Karnataka, targeting urban and semi-urban consumers through its network of branded stores.
Average Trading Volume: 21,159
Technical Sentiment Signal: Strong Buy
Current Market Cap: 98.09B INR
Learn more about MEDPLUS stock on TipRanks’ Stock Analysis page.